WGS
GeneDxBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-18
Current thesis
Faster commercial adoption, sustained payer wins, and operating‑leverage improvements drive durable revenue growth and justify multiple expansion toward the top of consensus.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta 0.0.
What can break
Adverse payer reimbursement or coverage delays
Momentum
44
Value
49
Sentiment
74
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $155.00 · Bull $190.00 · Bear $120.00
Data freshness
Prices
As of 2026-06-18
Fundamentals
As of 2026-06-15 • Vendor: Data Vendor v1
Scores
As of 2026-06-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-16 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-18
Investment thesis
As of 2026-06-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $156.67
Why
Momentum44 · Δ7d +40.1
Value49 · Δ7d -0.2
Sentiment74 · Δ7d 0.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
44
34% active weight
Current posture
7d trendImproving
Δ7d
+40.1
Δ21d
+43.8
Value
49
32% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-0.6
Sentiment
74
33% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade B. Momentum 44.3 / Value 48.6 / Sentiment 74.0
Fundamentals (TTM)As of 2026-06-15
Fundamentals (TTM)
As of 2026-06-15
Market Cap
$1.82B
Beta
2.10
Shares Out
28.9M
P/E (TTM)
2123.4
P/S (TTM)
9.45
P/FCF (TTM)
245.76
Rev YoY
+51.9%
EPS YoY
+13.6%
Gross Margin
+69.6%
Op Margin
+2.5%
Net Debt
-$69.11M
Current Ratio
2.71
As of 2026-06-18 • Updated nightlySource: Internal modelMethodology